Results of the European Glaucoma Prevention Study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.OPHTHA.2004.11.030PMID 15745761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Results of the betaxolol versus placebo treatment trial in ocular hypertension

  2003cited by this paper
• Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

  2003cited by this paper
• Reproducibility of evaluation of optic disc change for glaucoma with stereo optic disc photographs.

  2003cited by this paper
• Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

  2002cited by this paper
• The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

  2002cited by this paper
• The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

  2002cited by this paper
• The European glaucoma prevention study design and baseline description of the participants.

  2002cited by this paper
• Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.

  2001cited by this paper
• Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.

  2001cited by this paper
• Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).

  2001cited by this paper
• Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study.

  2000cited by this paper
• Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial

  2000cited by this paper
• Antiglaucoma medications: a review of safety and tolerability issues related to their use.

  2000cited by this paper
• A quantifiable alternative to double data entry.

  2000cited by this paper
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

  2000cited by this paper
• Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.

  2000cited by this paper
• The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

  2000cited by this paper
• Early Manifest Glaucoma Trial: design and baseline data.

  1999cited by this paper
• The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients.

  1999cited by this paper
• Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure

  1998cited by this paper
• Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.

  1998cited by this paper
• The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group.

  1998cited by this paper
• Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension

  1998cited by this paper
• Beta-blocker-induced complications and the patient with glaucoma. Newer treatments to help reduce systemic adverse events.

  1998cited by this paper
• Two‐year Safety Study of Dorzolamide as Monotherapy and with Timolol and Pilocarpine

  1998cited by this paper
• Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.

  1998cited by this paper
• Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.

  1997cited by this paper
• A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.

  1996cited by this paper
• A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

  1995cited by this paper
• Risk factors for open-angle glaucoma. The Barbados Eye Study.

  1995cited by this paper
• Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment.

  1995cited by this paper
• Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey.

  1994cited by this paper
• Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open‐angle glaucoma

  1993cited by this paper
• Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?

  1992cited by this paper
• Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.

  1991cited by this paper
• A comparison of treated and untreated glaucoma suspects.

  1991cited by this paper
• A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects.

  1989cited by this paper
• Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.

  1989cited by this paper
• Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture.

  1989cited by this paper
• Tables of the number of patients required in clinical trials using the logrank test.

  1982cited by this paper
• Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects.

  1980cited by this paper

• Adherence of glaucoma intervention studies to World Glaucoma Association guidelines.

  2026cites this paper
• Tobacco smoking is not associated with primary open-angle glaucoma: a systematic review and meta-analysis

  2026cites this paper
• Applications of machine learning in glaucoma diagnosis based on tabular data: a systematic review

  2025cites this paper
• Machine learning-assisted image analysis techniques for glaucoma detection

  2025cites this paper
• Lights and Shadows on Artificial Intelligence in Glaucoma: Transforming Screening, Monitoring, and Prognosis

  2025cites this paper
• Relationship between corneal stiffness and glaucoma severity: clinical insights from Corvis ST technology.

  2025cites this paper
• The impact of treatment modality on quality of life in glaucoma patients: findings from a clinical survey study in Augusta, GA

  2025cites this paper
• [Open-angle glaucoma: Who is affected and what are the risk factors?]

  2025cites this paper
• Combined Probability Test for Sectoral Progression of the Circumpapillary Retinal Nerve Fiber Layer Thickness

  2025cites this paper
• A deep semi-supervised learning approach to the detection of glaucoma on out-of-distribution retinal fundus image datasets

  2025cites this paper
• Clinical outcomes of Hydrus Microstent implantation for open-angle glaucoma: Results from a large academic center.

  2025cites this paper
• Corneal Biomechanical Changes Induced by Chronic Elevated Intraocular Pressure: Implications for Glaucoma Pathogenesis and Management

  2025cites this paper
• Intraocular pressure correlation to progressive retinal nerve fiber layer loss in primary open angle glaucoma as measured by standard and modified goldmann applanation tonometers

  2025cites this paper
• The need for more pragmatic trials in glaucoma research

  2024cites this paper
• Micropulse Transscleral Cyclophotocoagulation in Non-Incisional Eyes with Ocular Hypertension and Primary Open-Angle Glaucoma

  2024cites this paper
• Main morphofunctional correlations between indicators of intraocular pressure fluctuations and glaucomatous optic neuropathy progression

  2024cites this paper
• Bimatoprost SR for Glaucoma Therapy Implanted at the Slit-Lamp in a Real-World Setting

  2024cites this paper
• Harnessing the power of longitudinal medical imaging for eye disease prognosis using Transformer-based sequence modeling

  2024cites this paper
• Harnessing the power of longitudinal medical imaging for eye disease prognosis using Transformer-based sequence modeling

  2024cites this paper
• Severe systemic adverse reactions to ophthalmic timolol in a CYP2D6 homozygous *4 allele carrier: a case report.

  2023cites this paper
• Five-year visual field outcomes of the HORIZON trial.

  2023cites this paper
• Structure-function relationship in glaucoma: Optical coherence tomography en face imaging vs. red-free fundus photography

  2023cites this paper
• Adherence to Ocular Hypotensive Medication in Patients With Primary Open Angle Glaucoma in Ghana

  2023cites this paper
• The Japan Glaucoma Society guidelines for glaucoma 5th edition

  2023cites this paper
• Congenital Aniridia: Clinical Features and Therapeutic Approaches (Case Report)

  2023cites this paper
• Three‐year outcomes of an optometrist‐led virtual clinic for new glaucoma referrals

  2023cites this paper
• Challenging the "Topical Medications-First” Approach to Glaucoma: A Treatment Paradigm in Evolution

  2023cites this paper
• Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma

  2023cites this paper
• Agreement of Diagnostic Classification Between Structural Parameters in Pre-Perimetric and Early Perimetric Glaucoma

  2022cites this paper
• THE NATURAL HISTORY OF UNTREATED OCULAR HYPERTENSION AND GLAUCOMA PATIENTS.

  2022cites this paper
• Erroneous assumption of ocular hypertension in patients with elevated intraocular pressure

  2022influential citation
• The “Topography” of Glaucomatous Defect Using OCT and Visual Field Examination

  2022cites this paper
• Evaluation of UNC OCT Index for Diagnosis of Early Glaucoma.

  2022cites this paper
• Two-year visual field outcomes of the treatment for advanced glaucoma study (TAGS).

  2022cites this paper
• Evaluation of the Efficacy Duration of Topical Therapies in Eyes with Primary Open-Angle Glaucoma

  2022cites this paper
• Interventions to reduce loss to follow up in common retinal pathology: A systematic review

  2022cites this paper
• Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• Multicenter, Prospective, Randomized, Single Blind, Cross-Over Study on the Effect of a Fixed Combination of Citicoline 500 mg Plus Homotaurine 50 mg on Pattern Electroretinogram (PERG) in Patients With Open Angle Glaucoma on Well Controlled Intraocular Pressure

  2022cites this paper
• Impact of Systemic Comorbidities on Ocular Hypertension and Open-Angle Glaucoma, in a Population from Spain and Portugal

  2022cites this paper
• A multi-feature deep learning system to enhance glaucoma severity diagnosis with high accuracy and fast speed

  2022cites this paper
• Increased risk of open-angle glaucoma in non-smoking women with obstructive pattern of spirometric tests

  2022cites this paper
• Incidence of Glaucoma Progression and Rate of Visual Field Deterioration in a Cohort of Urban Ghanaians

  2022cites this paper
• Discrimination Between Healthy Eyes and Those With Mild Glaucoma Damage Using Hemoglobin Measurements of the Optic Nerve Head

  2022cites this paper
• Parafoveal vessel Density Dropout May Predict Glaucoma Progression in The Long-Term Follow Up

  2022cites this paper
• Therapeutic Role of Element Anhydrase Inhibitors in Treatment of Glaucoma: A Review

  2021cites this paper
• Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic

  2021cites this paper
• Evaluation of Macular and Retinal Ganglion Cell Count Estimates for Detecting and Staging Glaucoma

  2021cites this paper
• The Association Between Intraocular Pressure and Visual Field Worsening in Treated Glaucoma Patients

  2021cites this paper
• Assessing glaucoma in retinal fundus photographs using Deep Feature Consistent Variational Autoencoders

  2021cites this paper
• Estimating Ganglion Cell Complex Rates of Change With Bayesian Hierarchical Models

  2021cites this paper
• The American Glaucoma Society 100: Articles with Significant Impact on Clinical Glaucoma Care.

  2021cites this paper
• A novel approach to event-based progression analysis in glaucomatous visual fields

  2021cites this paper
• Improving event-based progression analysis in glaucomatous visual fields

  2021cites this paper
• Correlation of Vertical Cup Disc Ratio and Matrix FDT Mean Deviation in Primary Open Angle Glaucoma Patients

  2021cites this paper
• Corneal hysteresis as a risk factor for optic nerve head surface depression and retinal nerve fiber layer thinning in glaucoma patients

  2021cites this paper
• Risk factors for open-angle glaucoma and recommendations for glaucoma screening

  2021cites this paper
• Ocular Hypertension in Blacks

  2021cites this paper
• Detecting Progression in Patients With Different Clinical Presentations of Primary Open-angle Glaucoma

  2021cites this paper
• A simplified combined index of structure and function for detecting and staging glaucomatous damage

  2021cites this paper
• Progression from Ocular Hypertension into Glaucoma

  2021cites this paper
• Characterizing and quantifying the temporal relationship between structural and functional change in glaucoma

  2021cites this paper
• To evaluate the retinal nerve fiber layer thickness in different types of glaucoma

  2021cites this paper
• Distribution and analysis of intraocular pressure and its possible association with glaucoma in children

  2021cites this paper
• Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

  2021cites this paper
• Risikofaktoren für das Offenwinkelglaukom und Empfehlungen zur Glaukomfrüherkennung

  2020cites this paper
• Optical coherence tomography angiography in glaucoma

  2020cites this paper
• Current and new pharmacotherapeutic approaches for glaucoma

  2020cites this paper
• Attention-Guided 3D-CNN Framework for Glaucoma Detection and Structural-Functional Association Using Volumetric Images

  2020cites this paper
• Risk Assessment of Ocular Hypertension and the Use of Medication

  2020cites this paper
• The agreement between optical coherence tomography angiography and non-mydriatic retinal camera in estimating the optic nerve head parameters and relations with the peripapillary vessel density in primary open-angle glaucoma

  2020cites this paper
• Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram

  2020cites this paper
• Rates of Glaucomatous Structural and Functional Change from a Large Clinical Population: The Duke Glaucoma Registry Study.

  2020cites this paper
• A framework for assessing glaucoma progression using structural and functional indices jointly

  2020cites this paper
• Primary Open-Angle Glaucoma Preferred Practice Pattern®.

  2020cites this paper
• Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I

  2020cites this paper
• FUNCTIONAL ASSESSMENT OF GLAUCOMA PROGRESSION: UNCOVERING PROGRESSION.

  2020cites this paper
• Quantitative analysis of retinal nerve fiber layer defect in early open-angle glaucoma with normal intraocular pressure

  2020cites this paper
• Progression in Glaucoma

  2020cites this paper
• Review of Longitudinal Glaucoma Progression: 5 Years after the Shaffer Lecture.

  2020cites this paper
• The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma

  2020cites this paper
• Efficacy and safety of ultrasonic circular cyclocoagulation with second-generation probe in glaucoma: A retrospective study

  2020cites this paper
• Optical Coherence Tomography Angiography in Glaucoma

  2020cites this paper
• Progression from ocular hypertension to visual field loss in the English hospital eye service

  2020cites this paper
• Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II

  2020cites this paper
• Ингибиторы карбоангидразы в лечении глаукомы. Обзор. Часть 1

  2020cites this paper
• Variability of the risk factors measurements and 5-year glaucoma risk estimation.

  2020influential citation
• Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern®.

  2020cites this paper
• Developing an individualized structure-function approach for early detection of progression. BY SAMPSON LISTOWELL ABU, OD; KOOSHA

  2019cites this paper
• Corneal biomechanics and biomechanically corrected intraocular pressure in primary open-angle glaucoma, ocular hypertension and controls

  2019cites this paper
• Screening, Diagnosis, and Management of Open Angle Glaucoma

  2019cites this paper
• Intraocular Pressure as a Risk Factor

  2019cites this paper
• Ophthalmic Diagnostic Imaging: Glaucoma

  2019cites this paper
• Роль гипотензивного режима в достижении целевого уровня офтальмотонуса у пациентов с первичной открытоугольной глаукомой (результаты многоцентрового аналитического исследования)

  2019cites this paper
• Systematic reviews and randomised controlled trials on open angle glaucoma

  2019cites this paper
• Прогрессирование глаукомной оптиконейропатии: результаты многолетнего наблюдения

  2019cites this paper
• The importance of corneal assessment in a glaucoma suspect – a review

  2019cites this paper
• Longitudinal Macular Structure-Function Relationships in Glaucoma and Their Sources of Variability.

  2019cites this paper
• Glaucoma Optic Neuropathy Progression: the Results of Long-Term Follow-Up

  2019cites this paper
• An in vivo confocal, prospective, masked, 36 months study on glaucoma patients medically treated with preservative-free or preserved monotherapy

  2019cites this paper
• Significance of dynamic contour tonometry in evaluation of progression of glaucoma in patients with a history of laser refractive surgery

  2019cites this paper